3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Unknown
4
Completed
4
Recruiting
3
Terminated
2
Not yet recruiting
2
Active not recruiting
2
Withdrawn
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
1
Interventions
pembrolizumab
198
Nivolumab
146
Carboplatin
133
Specimen Handling
130
Magnetic Resonance Spectroscopy
116
Cyclophosphamide
112
Paclitaxel
106
Biopsy
97
Cisplatin
94
Radiotherapy
89
durvalumab
83
Dexamethasone
80
atezolizumab
73
Ipilimumab
66
Gemcitabine
60
Doxorubicin
60
Rituximab
59
Lenalidomide
56
Docetaxel
55
olaparib
51
Etoposide
51
Bevacizumab
51
Fluorouracil
49
Capecitabine
49
Radiation
47
Oxaliplatin
47
Radiosurgery
43
Prednisone
43
venetoclax
41
Taxes
41
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Active not recruiting
×
TP protocol
×
Clear all
NCT06143748
2026-04-23
EC-CRT-006
Sun Yat-sen University
Phase 2
Active not recruiting
46 enrolled
NCT05520619
2024-11-18
EC-CRT-002
Sun Yat-sen University
Phase 2
Active not recruiting
114 enrolled